Actively Recruiting
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
Led by Aloha Vision Consultants · Updated on 2025-10-09
50
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
Sponsors
A
Aloha Vision Consultants
Lead Sponsor
S
Sengi
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.
CONDITIONS
Official Title
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients undergoing age-related cataract surgery
- Planned use of the Catalys Precision Laser System
- Planned implantation of TECNIS intraocular lenses (IOLs)
You will not qualify if you...
- Moderate or severe eye diseases that increase risk of complicated cataract surgery, including pseudoexfoliation syndrome
- Zonular dehiscence
- History of eye trauma
- Prior refractive surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aloha Vision Consultants
‘Aiea, Hawaii, United States, 96701
Actively Recruiting
Research Team
A
Alana K Dunn
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here